These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Aberg H Acta Med Scand; 1969 May; 185(5):373-9. PubMed ID: 5808636 [No Abstract] [Full Text] [Related]
4. [Thyrotoxic cardiomyopathy. Analysis of 190 cases of thyrotoxicosis]. Hrnciar J Cas Lek Cesk; 1972 Jun; 111(25):575-80. PubMed ID: 5036055 [No Abstract] [Full Text] [Related]
5. [Hyperthyroidism and heart disease. Is thyrotoxic cardiomyopathy a disease entity?]. Toft P; Bøtker HE Ugeskr Laeger; 1993 May; 155(18):1354-7. PubMed ID: 8497965 [TBL] [Abstract][Full Text] [Related]
8. Unique aspects of atrial fibrillation: coexistence with other arrhythmias tachycardia-induced cardiomyopathy. Kolli A; Ellison KE Med Health R I; 2004 Apr; 87(4):108-10. PubMed ID: 15168636 [No Abstract] [Full Text] [Related]
9. Atrial fibrillation and embolism. Milliken JA Can Med Assoc J; 1983 Jun; 128(12):1370-2. PubMed ID: 6850461 [No Abstract] [Full Text] [Related]
10. Arterial embolism in thyrotoxicosis with atrial fibrillation. Bar-Sela S; Ehrenfeld M; Eliakim M Arch Intern Med; 1981 Aug; 141(9):1191-2. PubMed ID: 7259379 [TBL] [Abstract][Full Text] [Related]
11. [Embolic episodes after treatment of atrial fibrillation in a patient with thyrotoxicosis]. Hendriksen O; Petersen CL Ugeskr Laeger; 1995 Jul; 157(29):4138-9. PubMed ID: 7652995 [TBL] [Abstract][Full Text] [Related]